ReviewAntibiotics (Basel, Switzerland)2021
The Progress of Global Antimicrobial Resistance Governance and Its Implication to China: A Review.
Review in Antibiotics (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
16 citing papers in PubMed, 2 syntheses or guidelines pooled it.
- Prevalence and antimicrobial resistance ofOpen veterinary journal · 2025Pooled it
- The prevalence of bovine mastitis-associatedFrontiers in veterinary science · 2022Pooled it
- Spatiotemporal dynamics and multiple driving factors of antimicrobial resistance in China during the COVID-19 pandemic (2019-2023): a provincial panel data analysis.Antimicrobial agents and chemotherapy · 2026Article
- Effects of County Medical Community Central Pharmacy on antibiotic use in primary care: a multicenter quasi-experiment.International journal of clinical pharmacy · 2025Article
- Antimicrobial Resistance and the Blood-Brain Barrier: Complex Interactions and Implications for Neurological Health.Molecular neurobiology · 2025Review
- Implementing the Chinese mandatory antimicrobial stewardship program: barriers to continuous improvement.Health policy and planning · 2025Article
- Prevalence, antibiotic resistance, resistance and virulence determinants ofOne health (Amsterdam, Netherlands) · 2025Review
- Antibiotics governance in aquaculture: knowledge, practices, and challenges among stakeholders on the Volta Lake in Ghana.One health outlook · 2025Article
- Infection microenvironment-triggered nanoparticles eradicate MRSA by thermally amplified chemodynamic therapy and M1 macrophage.Journal of nanobiotechnology · 2024Article
- Antimicrobial resistance in China across human, animal, and environment sectors - a review of policy documents using a governance framework.The Lancet regional health. Western Pacific · 2024Review
- Evaluation of the participation of community pharmacists in family planning services: A nonrandomized controlled trial.Exploratory research in clinical and social pharmacy · 2024Article
- Applications and prospects of functional oligosaccharides in pig nutrition: A review.Animal nutrition (Zhongguo xu mu shou yi xue hui) · 2023Review
- Unpacking multi-level governance of antimicrobial resistance policies: the case of Guangdong, China.Health policy and planning · 2022Article
- Interventions to optimize the use of antibiotics in China: A scoping review of evidence from humans, animals, and the environment from a One Health perspective.One health (Amsterdam, Netherlands) · 2022Article
- Antibiotic Stewardship in Retail Pharmacies and the Access-Excess Challenge in China: A Policy Review.Antibiotics (Basel, Switzerland) · 2022Review
- Knowledge, attitude, and practice associated with antimicrobial resistance among medical students between 2017 and 2022: A survey in East China.Frontiers in public health · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
China has great potential for engaging in global actions on antimicrobial resistance (AMR) control. This study aims to summarize the process of global AMR governance and provide relevant policy recommendations on how China could take more initiative in the global AMR governance. We searched for academic articles and official document published or issued before December 2020 in e-journal databases, official websites of major organizations, and the relevant national ministries. This review revealed that global action on AMR control has experienced three stages: (1) The beginning stage (1980s and 1990s) when actions were mainly sponsored by high-income countries and AMR surveillance was focused on hospitals; (2) The rapid development stage (2000-2010) when global AMR governance began to concentrate on joint actions in multi-sectors, and developing countries were gradually involved in global actions; (3) The comprehensive stage (2011 to present) when global actions on AMR have covered various fields in different countries. China's AMR governance has fallen behind at the beginning but recently began to catch up with the global trend. The central government should take a far-fetched view, act decisively and positively towards the global efforts of addressing AMR to play a more active and greater role on the international stage.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.